Beijing 302 Hospital
Clinical trials sponsored by Beijing 302 Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cancer drug help cure hepatitis b? new trial launches Results expected Oct 2026 (estimated)
- Can a daily pill help breast cancer that outsmarts two antibody drugs? Results expected Dec 2026 (estimated)
- Shock therapy? no, just a gentle tingle to ease ERCP sedation risks Results expected Aug 2027 (estimated)
-
Can a Two-Drug combo wipe out hepatitis b for good?
Cure Not yet recruitingResearchers are testing whether adding a PD-1 antibody and pegylated interferon to standard antiviral pills can help people with chronic hepatitis B lose the hepatitis B surface antigen. The trial enrolls adults whose virus is already suppressed by nucleos(t)ide analogues and who…
Sponsor: Beijing 302 Hospital • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
Can the HPV vaccine protect those with HIV from cancer?
Vaccine Not yet recruitingThis trial tests whether the 9-valent HPV vaccine is safe and triggers a protective immune response in adults with HIV. People with HIV face higher risks of HPV infection and related cancers, but vaccine research in this group is limited. The study enrolls 60 HIV-infected adults …
Phase 1/2 • Sponsor: Beijing 302 Hospital • Aim: Vaccine
Last updated Sep 03, 2026 00:00 UTC
-
Can cord stem cells rescue a stubborn liver disease?
Disease control Not yet recruitingThis trial tests whether infusions of stem cells from human umbilical cords can help people with primary biliary cholangitis, a liver disease that damages bile ducts. It is for patients who have not responded well to the standard medicine, ursodeoxycholic acid. The study first ch…
Phase 1/2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Shock therapy? no, just a gentle tingle to ease ERCP sedation risks
Symptom relief Not yet recruitingThis study tests whether a gentle electrical current applied to specific points on the skin (called TEAS) can reduce side effects like low oxygen or blood pressure during a procedure to treat bile duct problems (ERCP). About 130 adults will be randomly assigned to receive either …
Sponsor: Beijing 302 Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC